Demystifying TScan Therapeutics: Insights From 4 Analyst Reviews
Media

Demystifying TScan Therapeutics: Insights From 4 Analyst Reviews

Latest Ratings for TCRX

Date Firm Action From To
Dec 2021 HC Wainwright & Co. Initiates Coverage On Buy
Aug 2021 Cowen & Co. Initiates Coverage On Outperform
Aug 2021 Morgan Stanley Initiates Coverage On Overweight

View More Analyst Ratings for TCRX

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for TCRX
DateFirmActionFromTo Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Aug 2021Cowen & Co.Initiates Coverage OnOutperform Aug 2021Morgan StanleyInitiates Coverage OnOverweight
View More Analyst Ratings for TCRX

View the Latest Analyst Ratings

read more 

Leave a Reply

Your email address will not be published. Required fields are marked *

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.